Skip to main content
. 2018 Oct 16;15:158. doi: 10.1186/s12985-018-1074-8

Fig. 3.

Fig. 3

Distribution of NT antibody titers and GMTs against CA16-B1a (a) and CA16-B1b (b) by age-group